financetom
Business
financetom
/
Business
/
GRAPHIC-US equity funds see first weekly outflow in six weeks
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GRAPHIC-US equity funds see first weekly outflow in six weeks
Apr 5, 2024 6:25 AM

April 5 (Reuters) - U.S. investors pulled back from

equity funds in the week ending April 3, marking an end to a

five-week buying streak, prompted by concerns over Federal

Reserve's interest rate cuts following recent robust

manufacturing and labour market data.

According to LSEG data, investors liquidated a net $3.28

billion worth of U.S. equity funds in their first weekly net

selling since Feb. 21.

They withdrew a net $2.63 billion out of U.S. large-cap

funds, ending a five-weeks-long buying trend. U.S. multi-,

small-, and mid-cap funds also witnessed disposals, amounting to

$1.19 billion, $215 million and $118 million, respectively.

The healthcare, consumer staples, and utilities sectors

logged a net $543 million, $219 million and $215 million worth

of outflow during the week. Conversely, communication services,

and metals & mining sectors saw $339 million and $269 million

worth of net accumulation.

In the debt funds market, investors extended purchases into

a second successive week as they accumulated about $7.24 billion

worth of U.S. bond funds.

U.S. short/intermediate investment-grade funds gained a

significant $4.57 billion during the week, the highest since

Feb. 7.

U.S. general domestic taxable fixed income, loan

participation, and short/intermediate government & treasury

funds meanwhile, secured $1.85 billion, $689 million and $313

million, respectively in inflows.

Money market funds, meanwhile received a sharp $70.01

billion during the week, the most in a week since Jan. 3.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Ryanair Seeing Strong Demand in Europe, CEO Says
Market Chatter: Ryanair Seeing Strong Demand in Europe, CEO Says
Aug 14, 2025
08:28 AM EDT, 08/14/2025 (MT Newswires) -- Ryanair ( RYAOF ) is witnessing strong demand in Europe and the airline is reasonably optimistic about hitting its targets for the summer, Reuters reported Thursday, citing an interview with CEO Michael O'Leary. We're seeing strong bookings through the peak summer months ... The fares are holding up, O'Leary told Reuters. According to...
Tilray Brands Seeks Nasdaq Extension to Meet Minimum Share Price Rule
Tilray Brands Seeks Nasdaq Extension to Meet Minimum Share Price Rule
Aug 14, 2025
08:28 AM EDT, 08/14/2025 (MT Newswires) -- Tilray Brands ( TLRY ) said Thursday it has asked Nasdaq for additional time to meet its minimum share price requirement and is considering options such as a reverse stock split to maintain its listing. The company said in March that Nasdaq had notified Tilray Brands ( TLRY ) about its non-compliance with...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Lilly signs up to $1.3 billion deal with Superluminal to develop obesity medicines
Lilly signs up to $1.3 billion deal with Superluminal to develop obesity medicines
Aug 14, 2025
Aug 14 (Reuters) - Superluminal Medicines said on Thursday it had signed a deal with U.S. drugmaker Eli Lilly ( LLY ) worth up to $1.3 billion to discover and develop obesity drugs. The deal will give Lilly access to Superluminal's proprietary platform to discover drug targets related to cardiometabolic diseases and obesity. Superluminal's lead oral obesity drug candidate is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved